Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CYP4F2 |
| Upstream (Parents) |
|---|
| (<<) CBS → CYP4F2 |
| (<<) GOT1 → CYP4F2 |
| (<<) GRHPR → CYP4F2 |
| (<<) HSD17B2 → CYP4F2 |
| (<<) MT1P2 → CYP4F2 |
| (<<) ORM1 → CYP4F2 |
| (<<) SAA4 → CYP4F2 |
| (<<) SOD1 → CYP4F2 |
| Downstream (Children) |
|---|
| CYP4F2 → ACTG1 (>>) |
| CYP4F2 → AIFM1 (>>) |
| CYP4F2 → ALDOA (>>) |
| CYP4F2 → ARSD (>>) |
| CYP4F2 → ASNS (>>) |
| CYP4F2 → BDH1 (>>) |
| CYP4F2 → CD83 (>>) |
| CYP4F2 → CTPS (>>) |
| CYP4F2 → CYP1A1 (>>) |
| CYP4F2 → CYP1A2 (>>) |
| CYP4F2 → DYNLL1 (>>) |
| CYP4F2 → E2F5 (>>) |
| CYP4F2 → ENO3 (>>) |
| CYP4F2 → GNA12 (>>) |
| CYP4F2 → GPX2 (>>) |
| CYP4F2 → HDAC6 (>>) |
| CYP4F2 → HK1 (>>) |
| CYP4F2 → HSD11B1 (>>) |
| CYP4F2 → HYAL1 (>>) |
| CYP4F2 → MAFF (>>) |
| CYP4F2 → MLXIPL (>>) |
| CYP4F2 → MT1G (>>) |
| CYP4F2 → NNMT (>>) |
| CYP4F2 → PCK2 (>>) |
| CYP4F2 → PIK3R1 (>>) |
| CYP4F2 → PKM2 (>>) |
| CYP4F2 → PSAT1 (>>) |
| CYP4F2 → RBKS (>>) |
| CYP4F2 → RDH16 (>>) |
| CYP4F2 → RXRA (>>) |
| CYP4F2 → SLC20A1 (>>) |
| CYP4F2 → SPR (>>) |
| CYP4F2 → ST3GAL6 (>>) |
| CYP4F2 → STK17B (>>) |
| CYP4F2 → TAGLN2 (>>) |
| CYP4F2 → TFPI2 (>>) |
| CYP4F2 → TRIB3 (>>) |
| CYP4F2 → TRIM32 (>>) |
| CYP4F2 → TUBA1B (>>) |
| CYP4F2 → UBE2C (>>) |
